Infectious Disease
1870s–1880s, Bitterroot Valley, Montana, USA (settler and Indigenous oral/clinical accounts); formally described in medical literature by Edward Maxey in 1899
Rocky Mountain spotted fever was a mysterious and frequently fatal illness that confounded physicians in the American West for decades before its causative agent and transmission mechanism were identified in the early twentieth century. Early researchers risked and sometimes lost their lives attempting to understand the disease through field investigation and laboratory experimentation. The unraveling of its origins represented one of the landmark achievements of American infectious disease research.
Historical Narrative
The earliest recognized accounts of Rocky Mountain spotted fever emerged from the Bitterroot Valley of Montana in the 1870s and 1880s, where settlers and Indigenous peoples in the region referred to it by grim colloquial names reflecting its devastating mortality, including 'black measles' due to the characteristic skin changes that appeared in severe cases. Local physicians were largely baffled by the illness, which swept through communities during certain seasons and killed a significant proportion of those it struck. Some early observers speculated that the disease arose from environmental conditions particular to the mountain valleys, including miasmatic theories involving soil disturbances or water sources.
The systematic scientific investigation of the disease began in earnest at the turn of the twentieth century. Edward Maxey, a physician practicing in Idaho, published one of the first formal clinical descriptions of the condition in 1899, drawing attention to its geographic clustering and seasonal pattern. His observations helped stimulate interest among researchers affiliated with the newly expanding apparatus of American public health science.
Howard Taylor Ricketts, a pathologist at the University of Chicago, conducted pivotal field investigations in Montana beginning around 1906. Working under genuinely dangerous conditions, Ricketts established through careful experimentation that the wood tick served as the vector responsible for transmitting the disease. He also identified a microorganism in the blood of infected animals and humans, laying the groundwork for understanding the causative agent, though he did not fully characterize it before his death from a related illness in 1910. In honor of his contributions, the genus of bacteria responsible for the disease and related conditions was later named Rickettsia.
Thomas McClintic and others at the United States Public Health Service continued investigations in the Bitterroot Valley in the years following Ricketts's death, working to confirm the tick transmission hypothesis and to explore whether tick populations could be controlled to reduce disease occurrence. The Rocky Mountain Laboratory in Hamilton, Montana, was established in 1928 specifically to study the disease, and it became a center of research into rickettsial illnesses more broadly.
Simão Pires Salgado and Brazilian researchers in the early twentieth century documented a clinically similar illness in South America, which came to be known as São Paulo typhus or Brazilian spotted fever. This work demonstrated that the disease, or a closely related one, was not confined to the North American continent, prompting a broader reconsideration of its geographic scope.
Reuben Spencer and others at the Rocky Mountain Laboratory worked through the 1920s and 1930s to develop a vaccine using tick-derived materials, a labor-intensive process that was used to protect laboratory workers and offered to some high-risk populations. The development of this early vaccine represented an important milestone in the effort to combat the disease through preventive means rather than solely through vector control.
The broader classification of spotted fever group rickettsioses, placing Rocky Mountain spotted fever within a family of related tick-borne diseases found across the Americas, Europe, Asia, and Africa, emerged gradually through the mid-twentieth century as comparative microbiology and serology advanced. The disease's history became a touchstone case in the development of American epidemiology and the institutional infrastructure of public health research.
Key Historical Figures
Historical narrative only — this page describes how Rocky Mountain spotted fever was understood historically. It is not medical advice and does not describe current diagnosis or treatment. Sourced from verified medical history references (NIH, Encyclopaedia Britannica, and standard medical history texts). See our medical disclaimer.